| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433841A1 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2426659A1 Method for treatment of tumors using combination therapy |
| 08/28/2002 | WO2001064242A1 Drugs for ameliorating retinal function |
| 08/28/2002 | EP1234880A1 Novel protein tab2 |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234878A1 Use of disease-associated gene |
| 08/28/2002 | EP1234877A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
| 08/28/2002 | EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 08/28/2002 | EP1234875A1 Novel metalloprotease having aggrecanase activity |
| 08/28/2002 | EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234820A1 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234586A2 Hepatoselective pharmaceutical actives |
| 08/28/2002 | EP1234581A1 Wound contraction inhibitors |
| 08/28/2002 | EP1234578A2 Antitumor and antiviral medications and method for producing the same |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234047A1 Drug inducible system and use thereof |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234042A1 Protein 27875, a human adam-ts homolog |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234036A2 Compositions and methods for the treatment of immune related diseases |
| 08/28/2002 | EP1234035A1 Human cytokine receptor |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234033A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 08/28/2002 | EP1234032A1 Novel nucleic acid and polypeptide |
| 08/28/2002 | EP1234031A2 B7-h1, a novel immunoregulatory molecule |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233986A1 Reduced side-effect hemoglobin compositions |
| 08/28/2002 | EP1233985A1 Collagen |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233978A1 Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| 08/28/2002 | EP1233977A1 Interleukin-1 homologue, mat il-1h4 |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233974A2 37 staphylococcus aureus genes and polypeptides |
| 08/28/2002 | EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 08/28/2002 | EP1233811A2 Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use |
| 08/28/2002 | EP1233791A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233785A1 "bonzo" chemokine receptor antibodies and ligands |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233780A1 Identification of sortase gene |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233776A1 Urotensin-ii cyclic analogs |
| 08/28/2002 | EP1233775A2 Tyrosine- and tryptophan-containing peptides as antioxidants |
| 08/28/2002 | EP1233774A1 Urotensin-ii analogs |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1233738A1 Use of nonimmunosuppressive cyclosporin derivatives for hair growth |
| 08/28/2002 | EP0973731B1 Hydroxamic acid derivatives |
| 08/28/2002 | EP0933995A4 Method of treating endothelial injury |
| 08/28/2002 | EP0912192B1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/2002 | EP0877626B1 Anti-cd18 antibodies for use against stroke |
| 08/28/2002 | EP0862454B1 Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8 for treating infections |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/28/2002 | EP0829011B1 Inhibition of amylin release |
| 08/28/2002 | EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein |
| 08/28/2002 | EP0804489B1 Antigenic preparation for treatment or prevention of helicobacter infection |
| 08/28/2002 | EP0794966B1 Humanized antibodies to cd38 |
| 08/28/2002 | EP0794961B1 Lhrh antagonist peptides |
| 08/28/2002 | EP0772452B1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii |
| 08/28/2002 | EP0671905B1 Stable protein: phospholipid compositions and methods |
| 08/28/2002 | CN1366051A Modifying method and application of exilis protein gene |
| 08/28/2002 | CN1366042A Process for preparing recombinant deoxyribonuclease I |
| 08/28/2002 | CN1365984A Parathyroid hormone analog and its preparing process by recombination |
| 08/28/2002 | CN1365983A Human alpha interferon derivative with superstrong antiviral activity |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/28/2002 | CN1089581C Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and process for preparing said preparation |
| 08/28/2002 | CN1089546C Method for raising pigs and promoting them stronger |
| 08/28/2002 | CA2401557A1 Medecine for improving retinal functions |
| 08/27/2002 | US6441158 Oligomers that bind to ku protein |
| 08/27/2002 | US6441157 Grass pollen |
| 08/27/2002 | US6441156 Calcium channel compositions and methods of use thereof |
| 08/27/2002 | US6441154 Human proteases and polynucleotides encoding the same |
| 08/27/2002 | US6441153 Human carboxypeptidases and polynucleotides encoding the same |
| 08/27/2002 | US6441145 Transgenically produced Antithrombin III |
| 08/27/2002 | US6441142 Detecting and quantifying allergens in foods; monoclonal antibody having antigen combining site with specificity for amino acid sequence arachis hypogaea ii; hybridoma cell lines which produce the antibodies |
| 08/27/2002 | US6441141 Synthetic peptides, antibodies against them and their use |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441135 Bak binding protein, DNA encoding the protein, and methods of use thereof |
| 08/27/2002 | US6441134 Isolated Candida albicans oligopeptide transporter gene |
| 08/27/2002 | US6441132 Of given amino acid sequence (6-12 amino acids), including d-tryptophan residues; useful as anticonvulsant or neuroprotective agents |
| 08/27/2002 | US6441130 Form triple stranded structures with nucleic acids |
| 08/27/2002 | US6441053 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 08/27/2002 | US6441040 200 parts s-(3-hydroxypropyl)-l-cysteine, 78 parts corn starch, 1 part talc, and 1 part magnesium stearate does not discolor after 12 months at room temperature, or 3 months at 40 degree c, or 1 month at 50 degree c |
| 08/27/2002 | US6441026 And an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor |
| 08/27/2002 | US6441022 Use as hypolipidemic |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440985 Methods for treating viral infections |